Cases 11 - 20 of 1,927
UCB, Inc. v. Annora Pharma Private Limited
as 24-1056
Plaintiff / Appellee:
UCB, INC. and UCB BIOPHARMA SRL
Defendant:
ANNORA PHARMA PRIVATE LIMITED, APOTEX INC. and APOTEX CORP.
Defendant / Appellant:
MSN PHARMACEUTICALS, INC. and MSN LABORATORIES PRIVATE LTD.
Galderma Laboratories, L.P. et al v. Apotex Inc. et al
as 1:2022cv00724
Plaintiff:
Galderma Laboratories, L.P. and TCD Royalty Sub LP
Defendant:
Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
GW RESEARCH LIMITED v. TEVA PHARMACEUTICALS, INC. et al
as 2:2023cv03914
Plaintiff:
GW RESEARCH LIMITED
Defendant:
TEVA PHARMACEUTICALS, INC., APOTEX INC., PADAGIS US LLC and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Apotex Inc. v. Boehringer lngelheim Pharmaceuticals, Inc. et al
as 1:2023cv00704
Plaintiff:
Apotex Inc.
Defendant:
Boehringer lngelheim Pharmaceuticals, Inc., Boehringer lngelheim International GMBH, Boehringer lngelheim Corporation and others
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
OYSTER POINT PHARMA, INC. v. APOTEX, INC.,
as 2:2023cv03860
Plaintiff:
OYSTER POINT PHARMA, INC.
Defendant:
APOTEX, INC.,
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Gilead Sciences, Inc. v. Apotex Inc. et al
as 1:2023cv00774
Plaintiff:
Gilead Sciences, Inc.
Defendant:
Apotex Inc., Apotex Corp., MSN Laboratories Private Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
as 1:2021md03017
In Re:
Xarelto (Rivaroxaban) ('310) Patent Litigation
Not Classified By Court:
Clerk of MDL Panel, Lupin Limited, Lupin Pharmaceuticals, Inc. and others
Counter Defendant:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Astellas Pharma Inc. et al v. Sandoz Inc. et al
as 1:2020cv01589
Defendant:
Sawai Pharmaceutical Co., Ltd., Cadila Healthcare Ltd. doing business as Zydus Cadila, Apotex Inc. and others
Plaintiff:
Astellas Pharma Inc., Astellas Ireland Co., Ltd. and Astellas Pharma Global Development, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Gilead Sciences, Inc. v. Apotex Inc. et al
as 1:2023cv00775
Plaintiff:
Gilead Sciences, Inc.
Defendant:
Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
OYSTER POINT PHARMA, INC. v. APOTEX, INC.,
as 3:2023cv03860
Plaintiff:
OYSTER POINT PHARMA, INC.
Defendant:
APOTEX, INC.,
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
